TCT-659: Natural History Of Optical Coherence Tomography Detected Edge Dissections 12 Months Following Drug-Eluting Stent Implantation  by unknown
TUESDAY, NOVEMBER 8, 2011, 8:00 AM - 10:00 AM
TCT-659
Natural History Of Optical Coherence Tomography Detected Edge Dissections
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Background: Angiographically detected edge dissections increase the risk of early
stent thrombosis (ST). OCT detects an increased number of edge dissections. The
clinical implication of these findings and their natural history remain unclear.
Methods: Edge dissections were defined as disruptions of the luminal surface in the
5 mm segments proximal and distal to the stent. Quantitative and qualitative OCT
analyses were performed every 0.5 mm at baseline and 12 months, and clinical
outcomes were assessed.
Results: Twenty edge dissections in 18 patients were studied; none were
angiographically visible. Median longitudinal dissection length was 2.9 (interquart
range (IQR) 1.6-4.3) mm. Eighteen (90%) dissections exhibited flaps with a median
maximum length of 1.27 (IQR 0.88-1.67) mm. Cavities and false lumina were visible
in 7 (35%) dissections with a median maximum width of 0.97 (IQR 0.87-1.25) and
1.62 (1.30-2.20) mm, respectively. Dissections extended into the media in 10 (50%)
cases and involved 2 quadrants in 4 (20%) cases. Sixteen of 20 dissections were
evaluated with IVUS which identified 8 of 16 OCT detected dissections. No ST or
target lesion revascularisation occurred up to 12 months. At follow-up, 90% of
dissections were completely healed (Fig A-C). The two cases showing signs of previous
dissection exhibited the longest flap (2.33 mm) and thickest false lumen cap (1.09 mm)
in the cohort, and both extended ≥4.3mm longitudinally.
Conclusion: OCT defined edge dissections appeared to be healed at 12 months with
no adverse clinical events. A cautious approach to the treatment of OCT defined edge
dissections should be considered.
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In Vivo Findings of Tissue Characteristics in High-Risk Coronary Artery
Plaques Using iMapTM IVUS
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Inga Narbute, Sanda Jegere, Andrejs Erglis
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Background: The rationale of atherosclerosis imaging is identification of high-risk
lesions, which may subsequentely lead to prevention of future cardiovascular events.
iMapTM tissue characterisation analysis is a novel technology which allows
identification of atherosclerotic plaque components (necrotic, fibrotic, lipidic tissue
and calcium) with certain degree of confidence, exclude from analysis echo negative
areas, such as areas masked behind calcified tissue that could be mistaken by automatic
analysis for necrotic tissue.The aim of the study was to investigate composition of
ruptured atherosclerotic plaque by iMap tissue characterisation in patients with ST
segment elevation myocardial infarction (STEMI).
Methods: 77 STEMI patients with TIMI 2-3 flow after thrombosuction in culprit artery
were included and IVUS Tissue Characterisation (iMap, IVUS, Boston Scientific
Corp., Minneapolis, MN, USA) were done. Clinical and angiographic follow-up with
IVUS for culprit vessel was performed after 296±48 days. IVUS catheter was advanced
10mm beyond the culprit lesion or stent at follow-up and was pulled back to a point of
20mm proximal to the lesion or stent at follow-up.
Results: Tissue Characterization showed high percentage of necrotic tissue in culprit
lesion and also in proximal segment of it (23.84 ± 11.19 and 22.73 ± 11.97,
respectively). At the follow-up we observed less percentage of necrotic core
(17.08±7.16 vs 22.73±21.46, p=0.003), and more percentage of fibrotic tissue
(70.22±9.94 vs 53.01±14.67, p=0.002) at the proximal segment when compared with
the index procedure. No restenosis or reocclusion of proximal segment at 10 month
follow-up were found.
Conclusion: Our study showed significant proportion of necrotic tissue in culprit
segment and 20mm proximal to culprit lesion as well as plaque stabilization in STEMI
patients by tissue characterisation analyses at 10 months follow-up. However, high
amount of necrotic tissue in proximal segment of the culprit lesion left uncovered by
stent were not associated with restenosis or reocclusion.
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Background: Impact of plaque composition on late acquired stent malapposition
(LSM) after drug-eluting stent (DES) implantation has not been evaluated.
Methods: We evaluated the relation between plaque components at poststenting
peristent area (between external elastic membrane and stent areas) and LSM after DES
implantation in 266 patients (314 native lesions; paclitaxel-eluting stent in 205 lesions,
sirolimus-eluting stent in 66 lesions, zotarolimus-eluting stent in 32 lesions and
everolimus-eluting stent in 11 lesions) in whom virtual-histology intravascular
ultrasound was performed at index and 12-month follow-up.
Results: LSM occurred in 24 patients with 30 lesions (10%) and there was no
significant difference in the incidence of LSM among 4 stent groups [21/205 (10%) in
paclitaxel-eluting stent, 4/34 (12%) in sirolimus-eluting stent, 6/66 (9%) in
zotarolimus-eluting stent and 1/11 (9%) in everolimus-eluting stent, P=0.5). Patients
with LSM were presented with more acute myocardial infarction (50% vs 28%,
P=0.026) and were more diabetics (50% vs 30%, P=0.030) and used multiple stents
(40% vs 16%, P=0.001) and overlapping stents (40% vs 14%, P<0.001) more
frequently compared with those without LSM. Lesions with LSM had more persistent
%necrotic core (NC) volumes compared with those without LSM (25.8±11.1% vs.
21.0±5.7%, P<0.001). Malapposition volume correlated with peristent %NC volume
(R=0.489, P=0.009) and peristent %FT volume (R=-0.472, P=0.006). Independent
predictors of LSM at 12-month follow-up were poststenting peristent %NC volume
[odds ratio (OR); 1.216, 95% CI; 1.053-1.405, P=0.008], acute myocardial infarction
(OR; 2.897, 95% CI; 1.675-4.118, P=0.029), and diabetes mellitus (OR; 2.413, 95%
CI; 1.543-3.996, P=0.038).
Conclusion: Poststenting persistent NC components, myocardial infarction, and
diabetes mellitus were associated with the development of LSM after DES
implantation.
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Impact of Post-Interventional Minimal Stent Area on Angiographic Restenosis
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Asan Medical Center, Seoul, Republic of Korea
Background: Stent underexpansion is a strong predictor of restenosis after bare-metal
stent and first-generation drug-eluting stent implantation. However, the implication of
underexpansion in Zotarolimus-eluting stent(ZES) and Everolimus-eluting stent(EES)
has not been addressed yet
Methods: Angiographic and intravascular ultrasound(IVUS) data immediately after
stenting and at 9-month follow-up were available in 912 patients with 990 lesions: 541
sirolimus-eluting stent(SES), 220 ZES, 229 EES. The minimal stent area(MSA)
predicts angiographic in-stent restenosis(ISR) was determined.
Results: The post-procedural IVUS MSA was 6.4±1.8 mm2, 6.2±2.1 mm2, 6.2±2.1
mm2 in SES, ZES, EES group. At 9-months follow-up, ISR was similar in SES, ZES
and EES group. (3.3%, 4.5%, 4.4%, p=0.53) Using multivariable logistic regression
analysis, the only independent predictor of ISR in each stent group was post-
interventional IVUS MSA. (p<0.001 for SES, p=0.003 for ZES and p=0.015 for ZES).
Using receiver operating characteristic analysis, post-interventional IVUS MSA was
shown as faithful discriminator between ISR and non-ISR(c=0.739 for SES, c=0.672
for ZES and c=0.639 for EES). The optimal cut-off value of post-interventional IVUS
MSA predict stent patency at 9 months were 5.5 mm2 for SES, 5.3 mm2 for ZES and
5.4 mm2 for EES.
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